Trials / Unknown
UnknownNCT05872828
Cross-sectional Study of Chinese Liver Cancer Patients
Anxiety, Depression, Immune Function and Quality of Life Among Chinese Liver Cancer Patients in the COVID-19 Pandemic Era
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 120 (estimated)
- Sponsor
- The Nethersole School of Nursing · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The goal of this cross-sectional study is to investigate the prevalence and risk factors of anxiety and depression and their relationships with immune functions and quality of life among liver cancer patients in the COVID-19 pandemic era. The objectives of this study are: 1. To examine the prevalence of anxiety and depression among patients with liver cancer during the COVID-19 pandemic. 2. To identify risk factors associated with anxiety and depression among these patients. 3. To determine the association between anxiety, depression, immune function, and quality of life among liver cancer patients. Participants will be asked to fill a digital questionnaire.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | No intervention | Observational study. No intervention will be adopted. |
Timeline
- Start date
- 2023-04-01
- Primary completion
- 2023-12-31
- Completion
- 2024-04-30
- First posted
- 2023-05-24
- Last updated
- 2023-11-22
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05872828. Inclusion in this directory is not an endorsement.